Atropine Sulfate Injection — FDA Drug Shortage

Current — Somerset Therapeutics, LLC

The FDA lists a drug shortage record for Atropine Sulfate Injection (injection) from Somerset Therapeutics, LLC with status Current. The shortage was first posted on 01/01/2012.

Shortage Details

Status
Current
Company
Somerset Therapeutics, LLC
Package NDC
70069-481-10
Dosage Form
Injection
Presentation
Atropine Sulfate, Injection, .4 mg/1 mL (NDC 70069-481-10)
Initial Posting
01/01/2012
Revised Date